Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2

被引:47
作者
Wohllk, N
Cote, GJ
Evans, DB
Goepfert, H
Ordonez, NG
Gagel, RF
机构
[1] UNIV TEXAS, MD ANDERSON CANCER CTR, ENDOCRINOL SECT, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANCER CTR, DIV SURG, HOUSTON, TX 77030 USA
[3] UNIV TEXAS, MD ANDERSON CANCER CTR, DIV PATHOL, HOUSTON, TX 77030 USA
关键词
CHRONIC LYMPHOCYTIC THYROIDITIS; C-CELL HYPERPLASIA; RET PROTOONCOGENE; EARLY DIAGNOSIS; NEURAL CREST; ACTIVATION; CHILDREN; ONCOGENE; GLAND; CHROMOSOME-10;
D O I
10.1016/S0889-8529(05)70310-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The discovery of RET proto-oncogene mutations causative for multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma now makes it possible to identify gene carriers with a high degree of certainty. The correct application of this information, however, requires an understanding of the specific mutations and the associated clinical syndromes. This review provides a synopsis of current trends in this field and their application to the clinical management of hereditary and sporadic medullary thyroid carcinoma.
引用
收藏
页码:1 / +
相关论文
共 100 条
[11]  
CARLSON KM, 1994, AM J HUM GENET, V55, P1076
[12]   SINGLE MISSENSE MUTATION IN THE TYROSINE KINASE CATALYTIC DOMAIN OF THE RET PROTOONCOGENE IS ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B [J].
CARLSON, KM ;
DOU, SS ;
CHI, D ;
SCAVARDA, N ;
TOSHIMA, K ;
JACKSON, CE ;
WELLS, SA ;
GOODFELLOW, PJ ;
DONISKELLER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1579-1583
[13]  
Carney J A, 1978, Pathobiol Annu, V8, P105
[14]  
CECCHERINI I, 1994, J ENDOCRINOL INVEST, V17, P201
[15]  
CHAKRAVARTI A, 1995, IN PRESS HUM MOL GEN
[16]   CYTOGENETIC CHARACTERIZATION OF 3 HUMAN AND 3 RAT MEDULLARY-THYROID CARCINOMA CELL-LINES [J].
COOLEY, LD ;
ELDER, FFB ;
KNUTH, A ;
GAGEL, RF .
CANCER GENETICS AND CYTOGENETICS, 1995, 80 (02) :138-149
[17]   RET PROTOONCOGENE MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 AND MEDULLARY-THYROID CARCINOMA [J].
COTE, GJ ;
WOHLLK, N ;
EVANS, D ;
GOEPFERT, H ;
GAGEL, RF .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1995, 9 (03) :609-630
[18]  
DECKER R, 1994, 5 INT WORKSH MULT EN
[19]   MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC [J].
DONISKELLER, H ;
DOU, SS ;
CHI, D ;
CARLSON, KM ;
TOSHIMA, K ;
LAIRMORE, TC ;
HOWE, JR ;
MOLEY, JF ;
GOODFELLOW, P ;
WELLS, SA .
HUMAN MOLECULAR GENETICS, 1993, 2 (07) :851-856
[20]  
DONOVAN DT, 1990, THYROID DISEASE ENDO, P501